Federal lawmakers requested action this week on restoring medical marijuana access to veterans, while proponents in Arizona came one step closer to qualifying to the November ballot. Keep reading to get the latest news and to find out how you can #TakeAction.
A bipartisan group of 11 lawmakers wrote a letter this week to Congressional leadership urging them to reconsider the Veterans Equal Access Amendment. Majorities in both the US House and Senate voted in May to include the provision as part of the Fiscal Year 2017 Military Construction, Veterans Affairs and Related Agencies Appropriations bill. However, Republicans sitting on the House Appropriations Committee decided last week to remove the language from the bill during a concurrence vote. The latest version of the Appropriations bill now awaits action by the Senate.
A separate coalition of US Senators and representatives also drafted a letter this week to DEA officials calling on the agency to move swiftly to reclassify marijuana under federal law, and to allow private producers to cultivate cannabis for clinical research purposes. “We request that you take immediate action to remove ‘cannabis’ and ‘tetrahydrocannabinols’ from Schedule I. We also ask that you issue a public statement informing the research community that the DEA, in compliance with international obligations, will accept new applications to bulk manufacture cannabis for medical and scientific purposes, to be approved on merit-based criteria,” lawmakers requested. In April, DEA officials pledged to issue guidance on the scheduling of cannabis within the first half of this year, a promise they recent walked back.
Arizona: The campaign to legalize the adult use of marijuana in Arizona yesterday turned in more than 200,000 signatures to the Secretary of State’s office. The campaign needs at least 150,000 of those signatures to be certified in order to qualify for this November’s ballot. Under the proposed initiative, those age 21 and older are permitted to possess up to 1 ounce of marijuana and grow up to six plants in their homes. The measure would also establish a licensing system for the commercial production and retail sale of cannabis.
Louisiana: Last week the city of New Orleans began implementing the new ordinance lowering the penalties associated with the possession of small amounts of marijuana. The ordinance was originally approved by City Council back in March in hopes of diverting police resources from minor crimes and keeping low-level offenders out of jail. The ordinance reclassifies minor marijuana possession offenses as non-criminal violations punishable by a fine-only: $40 for a first offense, $60 for a second, $80 for a third, and $100 for a fourth and beyond. Under state law, second and/or third convictions are punishable by between 6 months and 2 years in prison.
In statewide news, decision-makers at Louisiana State University and Southern University have agreed to apply for cultivation permits to supply medical cannabis. Under state law, qualified patients are permitted marijuana-infused products under a doctor’s recommendation. The state’s nascent medical cannabis program is anticipated to be up and running by 2018.
Pennsylvania: Members of the Harrisburg City Council are considering a measure to decriminalize the possession of small amounts of marijuana within the city limits. In recent days, members of the City Council amended the language to reduce the fines for possession, increase the fines for smoking marijuana in public and expand the effort to include possession of marijuana paraphernalia. The members are scheduled to vote on the measure on July 5th. If you live in Harrisburg you can find the contact information for City Council here.
Washington D.C.: The D.C. Health Department issued a report this week recommending the District legalize the retail sale of marijuana. Specifically, they recommend D.C. to “impose state taxes on production, distribution, and sales along with a licensed market participation, age restriction, and prohibitions on advertising and marketing to minors,” and ““use current regulatory models for tobacco and alcohol to base legislation to enact effective marijuana controls.”
Residents of Washington D.C. voted in 2014 to legalize the adult use of recreational marijuana. However Congressional leaders have prohibited the district from implementing a recreational market through annual budget riders. With this new report from the district’s health department and willingness from the Mayor and City Council to create a regulated market, it’s questionable how long Congress will continue to block the will of the people.
The NORML PAC is proud to announce its endorsement of Tim Canova, democratic primary challenger to US House member and DNC Chairwoman Debbie Wasserman-Schultz for Florida’s 23rd congressional district race.
Mr. Canova, a law school professor and political activist, is the first Democratic challenger to Representative Wasserman-Schultz since she’s held the office and NORML is excited to support his Congressional campaign.
In Florida, I supported the 2014 medical marijuana referendum that garnered about 58 percent of the vote state-wide, falling just short of the required 60 percent mark. My opponent, Debbie Wasserman Schultz, is a drug warrior who opposed the medical marijuana referendum. Calling marijuana a “gateway” drug, she refuses to allow her constituents in South Florida, in consultation with their doctors, to decide for themselves whether to utilize this plant-based medicine to alleviate pain and other symptoms of various illnesses and the side effects of other medications.
Certain industries have a special interest in keeping marijuana illegal – for example, the alcohol and pharmaceutical industries, both of which view recreational and medicinal use of marijuana as a competitive threat; and the private prison industry, which profits from warehousing people in jails, including for marijuana possession. Not surprisingly, having taken in lots of campaign donations from the alcohol, pharmaceutical, and private prison industries and their political action committees (PACs), Debbie Wasserman Schultz opposes medical marijuana and supports privatized prisons and mass incarceration. Unlike my opponent, I do not take any contributions from these special interests, or from any corporate interests at all.
In addition to Florida’s medical marijuana referendum, I also support the recent reforms by Miami-Dade and Broward Counties to decriminalize marijuana for personal use, and I call on the federal government to “de-schedule” marijuana from the list of controlled and dangerous substances.
In many of the states that have moved in the direction of legalization and regulation of marijuana for personal use, entire new industries are flourishing, adding jobs and increasing tax revenues, and crime rates are falling. While I support state efforts to allow individuals to make their own decisions, I also recognize the need to provide young people — and people of all ages — with many more job and educational opportunities in a time of decriminalization and legalization.
Earlier this year NORML released our 2016 Congressional Scorecard, an all-encompassing database of information related to marijuana law reform that graded members of Congress on their willingness to reform our country’s archaic marijuana laws. Representative Wasserman-Schultz was one of 37 congressional members to receive an “F” grade, a grade reserved for members who have spoken out against and actively opposed marijuana reforms.
NORML would like to commend Mr. Canova for his commitment toward amending America’s antiquated and overly punitive marijuana policies.
Please consider donating to Mr. Canova’s campaign here. Additionally, you can also volunteer for his campaign from the comfort of your own home! All you need is a phone, computer, and internet connection. This call tool on his website allows anyone to call into his district to contact voters to urge their support for Mr. Canova.
Representatives within the Democratic National Committee have approved provisions specific to marijuana law reform as part of the party’s 2016 platform.
A 15-person decision-making panel unanimously voted to adopt the following language:
“We believe that the states should be laboratories of democracy on the issue of marijuana, and those states that want to decriminalize marijuana should be able to do so. We support policies that will allow more research to be done on marijuana, as well as reforming our laws to allow legal marijuana businesses to exist without uncertainty. And we recognize our current marijuana laws have had an unacceptable disparate impact, with arrest rates for marijuana possession among African-Americans far outstripping arrest rates among whites despite similar usage rates.”
Though the language falls well short of calling for an end to federal cannabis prohibition, it nonetheless marks a stark contrast between the two major political parties.
Last week, Republican leaders in Congress quashed a number of proposed marijuana law reforms. Specifically, provisions previously voted on by Congress to expand medical cannabis access to eligible military veterans were removed by leadership during the conference committee process and earlier there was a decision to deny members the opportunity to vote on a Democrat-sponsored amendment that sought to permit banks and other financial institutions to engage in relationships with state-compliant marijuana businesses.
With many Congressional Republicans actively discouraging marijuana related reforms at the federal level, it’s motivating to see Democrats pro-actively finding ways to include the need for cannabis policy reform in the party’s national conversation.
This has been an exceptionally busy week at the state and federal level for marijuana law reform. Keep reading to get the latest news and to find out how you can #TakeAction.
A bipartisan coalition of House and Senate lawmakers have proposed legislation, the Medical Marijuana Research Act of 2016, to expedite clinical investigations into the safety and efficacy of cannabis. Passage of the measures — House Bill 5549 and Senate Bill 3077 — would expedite federal reviews of clinical protocols involving cannabis, provide greater access to scientists who wish to study the drug, and mandate an FDA review of the relevant science. #TakeAction
Arkansas: Representatives of the group Arkansas for Compassionate Care turned in over 100,000 signatures from registered voters this week in hopes of qualifying the 2016 Arkansas Medical Cannabis Act for the November ballot. The proposed initiative establishes a statewide program for the licensed production, analytic testing, and distribution of medicinal cannabis. Under the program, patients diagnosed by a physician with one of over 50 qualifying conditions – including ADHD, intractable pain, migraine, or post-traumatic stress – may obtain cannabis from one of up to 38 licensed non-profit care centers. Qualified patients who do not have a center operating in their vicinity will be permitted to cultivate their own medicine at home.
In 2012, 51 percent of voters narrowly rejected a similar statewide initiative, known as Measure 5. However, recent polling shows that support has increased dramatically since then, with 84 percent of registered Arkansas voters agreeing that “adults should be legally allowed to use marijuana for medical purposes.”
For more information on the campaign, please visit Arkansans for Compassionate Care.
California: Both the American Civil Liberties Union of California and the California Democratic Party have publicly endorsed the Adult Use of Marijuana Act (AUMA). The initiative, which is expected to appear on the November ballot, permits adults to legally grow (up to six plants) and possess personal use quantities of cannabis (up to one ounce of flower and/or up to eight grams of concentrate) while also licensing commercial cannabis production and retail sales. The measure prohibits localities from taking actions to infringe upon adults’ ability to possession and cultivate cannabis for non-commercial purposes.
Delaware: House lawmakers have overwhelmingly approved legislation, SB 181, to permit designated caregivers to possess and administer non-smoked medical marijuana formulations (e.g. oils/extracts) to qualifying patients “in a school bus and on the grounds or property of the preschool, or primary or secondary school in which a minor qualifying patient is enrolled.” Senate lawmakers previously approved the bill on June 9th.
Gov. Jack Markell, D-Delaware, is expected to sign the legislation into law. The measure will take effect upon the Governor’s signature. To date, two other states — Colorado and New Jersey — impose similar legislation.
Florida: Elected officials of yet another Florida county have voted to provide local law enforcement with the option to cite rather than arrest minor marijuana possession offenders. Osceola County commissioners passed the ordinance on Tuesday. The new ordinance is similar to those recently passed in Orlando, Tampa, Volusia County, Palm Beach County, Broward County, West Palm Beach, Key West, Hallandale, Miami Beach and Miami-Dade county.
New Jersey: Legislation to add PTSD to the list of qualifying conditions eligible for medical marijuana is moving forward through state legislature.
Members of the Assembly approved the legislation in a 56 to 13 vote on June 16th. On the same day, members of the Senate Health, Human Services and Senior Citizens Committee approved an identical measure, Senate Bill 2345, in a 6 to 3 vote. Thirteen states already allow PTSD patients to access medical marijuana including Delaware, Maryland, and Pennsylvania.
The measure now awaits a vote by the full Senate. #TakeAction
New York: Legislation has been approved to facilitate the processing and sale of hemp and locally produced hemp products. The measures, A 9310 and S 6960, expand upon New York’s existing hemp research program to permit for the sale, distribution, transportation and processing of industrial hemp and products derived from such hemp. Under existing law, licensed farmers are only permitted to engage in the cultivation of hemp for research purposes as part of an academic program.
Both chambers have approved the legislation so now it awaits a signature from Governor Andrew Cuomo.#TakeAction
Rhode Island: House and Senate lawmakers approved House Bill 7142, legislation to permit post-traumatic stress patients to be eligible for medical cannabis treatment and to accelerate access to those patients in hospice care. Members of both chambers overwhelmingly approved the measure. It now heads to the desk of Democratic Governor Gina Raimondo.#TakeAction
House and Senate lawmakers also approved legislation to create the “Hemp Growth Act “. This measure will classify hemp as an agricultural product that may be legally produced, possessed, and commercially distributed. The Department of Business Regulation will be responsible for establishing rules and regulations for the licensing and regulation of hemp growers and processors. The Department is also authorized to certify any higher educational institution in Rhode Island to grow or handle or assist in growing or handling industrial hemp for the purpose of agricultural or academic research. The legislation now awaits action from Governor Gina Raimondo. If signed, the law will take effect January 1, 2017.#TakeAction
Congressional leaders have moved in recent days to quash a number of proposed marijuana law reforms.
Specifically, provisions previously voted on by Congress to expand medical cannabis access to eligible military veterans were removed by leadership during the conference committee process. Members have yet to speak publicly as to why the language was removed. Both the Senate and the House versions of the Fiscal Year 2017 Military Construction, Veterans Affairs and Related Agencies Appropriations bill contained the marijuana-friendly provisions prior to the reconciliation process.
The move follows a decision earlier this week by Republican leaders on the House Rules Committee to deny members the opportunity to vote on a Democrat-sponsored amendment that sought to permit banks and other financial institutions to engage in relationships with state-compliant marijuana businesses. Senate Appropriations Committee members had approved a similar amendment last week by a vote of 16 to 14. That amendment, which is now included in the Senate’s version of the Financial Services and General Government appropriations bill, awaits further action on the Senate floor. If approved, the Senate bill will ultimately need to be reconciled in conference committee with House leadership.
In April, NORML released a Congressional Scorecard assigning letter grades ‘A’ through ‘F’ to every member of the US House and Senate based on their marijuana-related comments and voting records. To see what grades your Congressional members received, please click here.